Constantia Flexibles announced its latest development called Constantia TEOS, a new tamper-evident opening system for packages containing medical devices.
Developed in collaboration with customers, the system was originally designed for syringes housing tumor necrosis factor inhibitors, also called TNF Blockers. The key feature of Constantia TEOS is a tamper-evident peelable cover foil that is functionally destroyed during initial opening. According to Constantia, the cover foil provides reliable protection against the packaging’s illegal reuse.
“Drug counterfeiting continues to be an important issue worldwide, and fighting this threat is of paramount importance to us,” says Frederick J. Lutz, regional sales manager North America, Pharma Division for Constantia Flexibles, in a released statement. “In parallel with Constantia Flexibles’ broad range of other anti-counterfeiting features, TEOS helps ensure the safety and integrity of our customers’ products and, therefore, of patients and healthcare providers.”
Constantia TEOS also can incorporate a variety of optional overt and covert features that further assist with tamper evidence. Possibilities include holograms, customized security foil, special security pigments and inks, and unique-to-product security printing such as microtext, hidden graphics and built-in pattern deviations.
For more company information, visit http://www.cflex.com.